Boothbay Fund Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,184
| Closed | -$255K | – | 1687 |
|
|
2024
Q3 | $255K | Buy |
+8,184
| New | +$255K | 0.01% | 1135 |
|
|
2020
Q3 | – | Sell |
-151,900
| Closed | -$3.61M | – | 1099 |
|
|
2020
Q2 | $3.61M | Sell |
151,900
-12,100
| -7% | -$287K | 0.25% | 75 |
|
|
2020
Q1 | $2.95M | Buy |
+164,000
| New | +$2.95M | 0.24% | 85 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 897 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 814 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 788 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 786 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 789 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 823 |
|
|
2017
Q2 | – | Sell |
-6,500
| Closed | -$203K | – | 749 |
|
|
2017
Q1 | $203K | Sell |
6,500
-4,171
| -39% | -$130K | 0.04% | 512 |
|
|
2016
Q4 | $269 | Buy |
10,671
+2,114
| +25% | +$53 | 0.06% | 388 |
|
|
2016
Q3 | $212K | Buy |
+8,557
| New | +$212K | 0.05% | 451 |
|
|
2016
Q2 | – | Sell |
-13,334
| Closed | -$203K | – | 556 |
|
|
2016
Q1 | $203K | Buy |
+13,334
| New | +$203K | 0.15% | 172 |
|
|
2015
Q4 | – | Sell |
-13,913
| Closed | -$195K | – | 615 |
|
|
2015
Q3 | $195K | Buy |
+13,913
| New | +$195K | 0.09% | 311 |
|